Table 1.
PBO | GMB 120 mg | GMB 240 mg | |
---|---|---|---|
MSQ-RFR | 68.1 (14.5) | 66.2 (17.0) | 67.6 (13.7) |
MSQ-RFP | 81.9 (13.7) | 82.6 (15.8) | 83.5 (12.2) |
MSQ-EF | 79.8 (17.6) | 78.6 (22.5) | 82.4 (14.9) |
MSQ-Total | 74.6 (13.5) | 73.5 (16.7) | 75.3 (12.0) |
Note: Data are mean (SD).
Abbreviations: EF, Emotional Function domain; GMB, galcanezumab; MSQ, Migraine-Specific Quality-of-Life Questionnaire; PBO, placebo; RFP, Role Function-Preventive domain; RFR, Role Function-Restrictive domain; SD, standard deviation.